Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiocca

Showing results (531-540 of 728) with videos related to

Pageof 73
Sort By:
Scientific Reports|October 30, 2025
The selective serotonin reuptake inhibitor escitalopram oxalate negatively impacts the fracture healing in healthy adults and in osteoporotic ratsRoberta Carminati Shimano, Ariane Zamarioli, Ana Paula Macedo, et al.
Nature Cancer|November 10, 2022
Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunityLei Tian, Bo Xu, Yuqing Chen, et al.
Human Gene Therapy|August 1, 1994
Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 geneM X Wei, T Tamiya, M Chase, et al.
Neurosurgery Practice|October 30, 2025
Departments of Neurosurgery are Leaders in Highly Cited Glioblastoma ResearchMasih Tazhibi, Rishab Ramapriyan, Parker Kotlarz, et al.
Scientific Reports|July 27, 2016
Dynamic phosphorylation of Histone Deacetylase 1 by Aurora kinases during mitosis regulates zebrafish embryos developmentSara Loponte, Chiara V Segré, Silvia Senese, et al.
Nature Communications|October 9, 2021
An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastomaBo Xu, Lei Tian, Jing Chen, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 25, 2022
Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti-Tumor Immunity in Murine GlioblastomaSophie Lugani, Elias A Halabi, Juhyun Oh, et al.
Molecular and Cellular Biology|December 24, 2009
The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferationGordin Zupkovitz, Reinhard Grausenburger, Reinhard Brunmeir, et al.
Nature Medicine|July 30, 1999
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responsesK Ikeda, T Ichikawa, H Wakimoto, et al.
Molecular Neurobiology|August 14, 2024
Arming AAV9 with a Single-Chain Fragment Variable Antibody Against PD-1 for Systemic Glioblastoma TherapySemer Maksoud, Markus W Schweiger, Elie I Tabet, et al.
Pageof 73

Showing results (531-540 of 728) with videos related to

Sort By:
Pageof 73
Scientific Reports|October 30, 2025
The selective serotonin reuptake inhibitor escitalopram oxalate negatively impacts the fracture healing in healthy adults and in osteoporotic ratsRoberta Carminati Shimano, Ariane Zamarioli, Ana Paula Macedo, et al.
Nature Cancer|November 10, 2022
Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunityLei Tian, Bo Xu, Yuqing Chen, et al.
Human Gene Therapy|August 1, 1994
Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 geneM X Wei, T Tamiya, M Chase, et al.
Neurosurgery Practice|October 30, 2025
Departments of Neurosurgery are Leaders in Highly Cited Glioblastoma ResearchMasih Tazhibi, Rishab Ramapriyan, Parker Kotlarz, et al.
Scientific Reports|July 27, 2016
Dynamic phosphorylation of Histone Deacetylase 1 by Aurora kinases during mitosis regulates zebrafish embryos developmentSara Loponte, Chiara V Segré, Silvia Senese, et al.
Nature Communications|October 9, 2021
An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastomaBo Xu, Lei Tian, Jing Chen, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 25, 2022
Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti-Tumor Immunity in Murine GlioblastomaSophie Lugani, Elias A Halabi, Juhyun Oh, et al.
Molecular and Cellular Biology|December 24, 2009
The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferationGordin Zupkovitz, Reinhard Grausenburger, Reinhard Brunmeir, et al.
Nature Medicine|July 30, 1999
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responsesK Ikeda, T Ichikawa, H Wakimoto, et al.
Molecular Neurobiology|August 14, 2024
Arming AAV9 with a Single-Chain Fragment Variable Antibody Against PD-1 for Systemic Glioblastoma TherapySemer Maksoud, Markus W Schweiger, Elie I Tabet, et al.
Pageof 73